Product Image

Omega Joint Xtra

Nordic Naturals
4.7
★ ★ ★ ★ ★
(233 ratings)
Omega-3 1065 mg
Product Image
Score76
Well-chosen glucosamine, UC-II, and omega-3 amounts make this a strong joint-focused formula. Cost, capsule burden, and warfarin interaction require careful consideration.
How scoring works
Quantity:90 Softgel(s) • (30 servings)
Goals:
Joint Health
Skin Health

Score 76

Well-chosen glucosamine, UC-II, and omega-3 amounts make this a strong joint-focused formula. Cost, capsule burden, and warfarin interaction require careful consideration.
How scoring works
$45.86($1.52 per serving)
iHerb
$ 45.86
Vitacost
$ 57.95
Daily Vita
$ 49.26
Report prices

Analysis

Three softgels provide 1,500 mg glucosamine sulfate, 40 mg standardized UC-II cartilage, and 1,065 mg total omega-3. The combination addresses structural, immune-mediated, and inflammatory aspects of joint comfort.

Glucosamine and UC-II amounts match commonly used targets, giving the formula unusually strong joint focus. EPA and DHA are not separated, and oil source, form, freshness protection, and purity evidence are missing.

The high serving cost and three-softgel routine are meaningful trade-offs. It best fits users seeking a comprehensive joint formula rather than general omega-3 or metabolism support.

Who is it for
  • Adults seeking multi-pathway joint support
  • People who want glucosamine and UC-II together
  • Users comfortable with three softgels daily
Best for
  • Joint comfort and mobility
  • Combined structural and inflammatory support
  • A comprehensive joint supplement

Pros

  • Provides 1,500 mg glucosamine sulfate
  • Includes 40 mg standardized UC-II cartilage
  • Adds 1,065 mg total omega-3

Cons

  • EPA and DHA amounts are not stated
  • High serving cost
  • Three-softgel serving

Warnings

  • Glucosamine may strengthen warfarin's effect and increase bleeding risk.
  • Avoid use if you have a fish allergy unless the omega-3 source is confirmed suitable.
  • Glucosamine can cause digestive upset, while omega-3 may add to bleeding tendency with anticoagulant or antiplatelet medicines.

Nutrient quality

87 Highest impact

Glucosamine and standardized cartilage reach meaningful joint-focused amounts beside substantial total omega-3. Missing fatty-acid profile and quality details limit confidence.

.

Ingredient transparency

74 High impact

The joint actives and total omega-3 amount are clearly listed without a hidden blend. EPA and DHA, omega form, source, purity, directions, and excipients remain incomplete.

.

Customer satisfaction

64 Moderate impact

The supplied aggregate satisfaction signal is favorable and supported by meaningful response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

75 High impact

Meaningful active depth provides a credible value foundation. Missing fatty-acid and quality details prevent a stronger comparison.

.
Report analysis

Goals

Joint Health
Joint Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportA+ CoverageA+ Formula Quality
Omega-3 · 1065 mg

Glucosamine sulfate, UC-II cartilage, and omega-3s combine structural, immune-mediated, and inflammatory joint support. The glucosamine and UC-II amounts match widely used targets, while total omega-3 is substantial.

EPA and DHA are not separated, so the anti-inflammatory fatty-acid contribution cannot be fully assessed. Glucosamine may strengthen warfarin’s effect, so people using warfarin need clinician-guided monitoring.

Study evidence
Omega-3 Supportive 40 studies
Skin Health
Skin Health
Impact
Moderate effect
C Goal FitC+ Strength of SupportC CoverageD- Formula Quality
Omega-3 · 1065 mg

Omega-3 fats offer barrier support, but glucosamine and cartilage are primarily directed toward joints. The added cartilage ingredients have evidence for joint outcomes rather than skin structure or hydration.

The 1,065 mg total omega-3 amount is useful, but active EPA and DHA amounts are not separated. Glucosamine may increase the anticoagulant effect of warfarin and raise bleeding risk.

Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per serving
Calories
30 Calorie(s)
Total Fat
2 Gram(s)
Glucosamine Sulfate
1500 mg
UC-II standardized Cartilage
40 mg
Total Omega-3 Fatty Acids
1065 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
Omega-3 · 1065 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The three-softgel serving lists 1065 mg of total omega-3 without separate EPA and DHA amounts. Glucosamine and cartilage make it a broader joint formula, while the omega-3 form, source, antioxidants, and purity testing remain undisclosed. Glucosamine may strengthen the effect of warfarin and increase bleeding risk.

View ingredientView products
Loading alternative details
85 Performance

Ultimate Omega Lemon

Nordic Naturals
<p>Omega-3 quality is easier to assess, but it does not replace the original glucosamine and cartilage ingredients for joint-focused use. The 1,280 mg triglyceride-form serving adds wild-fish sourcing, antioxidant protection, and accessible purity records for a well-characterized daily option.</p>
81 Performance

Prenatal DHA 650 mg

Thorne
<p>Omega-3 quality is easier to assess, but it does not replace the original glucosamine and cartilage ingredients for joint-focused use. A DHA-rich 960 mg fish-oil serving uses a triglyceride form and includes antioxidant protection and contaminant testing, making the active profile easier to assess.</p>
73 Performance

Omega-3 Fish Oil Orange Flavor

Garden Of Life Minami
<p>Omega-3 quality is easier to assess, but it does not replace the original glucosamine and cartilage ingredients for joint-focused use. The concentrated softgel supplies 850 mg of total omega-3, although EPA, DHA, molecular form, source, antioxidant protection, and purity testing are not disclosed.</p>
70 Budget

Fish Oil 1000 mg

Spring Valley
<p>It lowers the supplied per-serving cost while retaining a relevant omega-3 source. The triglyceride-form oil declares 300 mg of omega-3 and 260 mg of combined EPA and DHA, though the individual fatty acids, source, purity, and oxidation details are missing.</p>
69 Budget

Real Krill

Doctor's Best
<p>It lowers the supplied per-serving cost while retaining a relevant omega-3 source. Krill phospholipids and astaxanthin support delivery and oxidation control, but the serving contains only 77 mg of omega-3 and does not separate EPA from DHA.</p>
76 Budget

Arctic Cod Liver Oil Orange

Nordic Naturals
<p>It lowers the supplied per-serving cost while retaining a relevant omega-3 source. Cod liver oil supplies 1,060 mg of total omega-3 with a named marine source, though EPA, DHA, molecular form, antioxidant protection, and purity evidence are missing.</p>
85 Value

Ultimate Omega Lemon

Nordic Naturals
<p>A lower supplied serving cost combines with a more useful ingredient or disclosure profile. The 1,280 mg triglyceride-form serving combines clear active-fatty-acid disclosure with wild-fish sourcing and accessible purity records.</p>
69 Value

Neptune Krill Oil 500 mg

NOW
<p>A lower supplied serving cost combines with a more useful ingredient or disclosure profile. The krill oil provides 250 mg of omega-3 with 450 mg of phospholipids and esterified astaxanthin, but it does not separate EPA from DHA.</p>
67 Value

Superior Omega-3 Krill Oil Ultra Strength 1000 mg

Schiff MegaRed
<p>A lower supplied serving cost combines with a more useful ingredient or disclosure profile. Krill phospholipids and astaxanthin provide a useful delivery system, while the 230 mg omega-3 amount and missing EPA/DHA split limit active potency.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  2. Effect of Losartan and Fish Oil on Plasma IL-6 and Mobility in Older Persons. The ENRGISE Pilot Randomized Clinical Trial.
    Pahor M; Anton SD; Beavers DP; Cauley JA; Fielding RA; Kritchevsky SB; Leeuwenburgh C; Lewis KH; Liu CK; Lovato LC; Lu J; Manini TM; McDermott MM; Miller ME; Newman AB; Radziszewska B; Stowe CL; Tracy RP; Walkup MP; Wu SS; Ambrosius WT · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Randomized trial289 participantsJoint Health forOmega-3
  3. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  4. The association of organophosphate flame retardants (OPFRs) exposure on omega-3 fatty acids metabolism: evidence derived from the United States general population.
    Hsu TH; Pan HY; Tsai KF; Kung CT; Huang WT; You HL; Li SH; Wang CC; Lee WC; Cheng FJ · Toxicology research · 2025
    Cross-sectional study1,350 participantsMetabolism Boost forOmega-3
  5. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  6. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  7. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  8. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  9. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  10. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  11. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  12. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  13. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3